These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 20671427)

  • 21. Methylation status analysis of cell cycle regulatory genes (p16INK4A, p15INK4B, p21Waf1/Cip1, p27Kip1 and p73) in natural killer cell disorders.
    Kawamata N; Inagaki N; Mizumura S; Sugimoto KJ; Sakajiri S; Ohyanagi-Hara M; Oshimi K
    Eur J Haematol; 2005 May; 74(5):424-9. PubMed ID: 15813917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic importance of MN1 transcript levels, and biologic insights from MN1-associated gene and microRNA expression signatures in cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study.
    Langer C; Marcucci G; Holland KB; Radmacher MD; Maharry K; Paschka P; Whitman SP; Mrózek K; Baldus CD; Vij R; Powell BL; Carroll AJ; Kolitz JE; Caligiuri MA; Larson RA; Bloomfield CD
    J Clin Oncol; 2009 Jul; 27(19):3198-204. PubMed ID: 19451432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA let-7a-3 gene methylation is associated with karyotyping, CEBPA promoter methylation, and survival in acute myeloid leukemia.
    Ko YC; Fang WH; Lin TC; Hou HA; Chen CY; Tien HF; Lin LI
    Leuk Res; 2014 May; 38(5):625-31. PubMed ID: 24703161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73.
    van Doorn R; Zoutman WH; Dijkman R; de Menezes RX; Commandeur S; Mulder AA; van der Velden PA; Vermeer MH; Willemze R; Yan PS; Huang TH; Tensen CP
    J Clin Oncol; 2005 Jun; 23(17):3886-96. PubMed ID: 15897551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specific patterns of gene methylation in natural killer cell lymphomas : p73 is consistently involved.
    Siu LL; Chan JK; Wong KF; Kwong YL
    Am J Pathol; 2002 Jan; 160(1):59-66. PubMed ID: 11786399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Promoter DNA methylation and expression levels of HOXA4, HOXA5 and MEIS1 in acute myeloid leukemia.
    Musialik E; Bujko M; Kober P; Grygorowicz MA; Libura M; Przestrzelska M; Juszczyński P; Borg K; Florek I; Jakóbczyk M; Siedlecki JA
    Mol Med Rep; 2015 May; 11(5):3948-54. PubMed ID: 25585874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allogeneic hematopoietic stem cell transplantation could improve survival of cytogenetically normal adult acute myeloid leukemia patients with DNMT3A mutations.
    Xu Y; Sun Y; Shen H; Ding L; Yang Z; Qiu H; Sun A; Chen S; Wu D
    Am J Hematol; 2015 Nov; 90(11):992-7. PubMed ID: 26223865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined testing for CCAAT/enhancer-binding protein alpha (CEBPA) mutations and promoter methylation in acute myeloid leukemia demonstrates shared phenotypic features.
    Szankasi P; Ho AK; Bahler DW; Efimova O; Kelley TW
    Leuk Res; 2011 Feb; 35(2):200-7. PubMed ID: 20970189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical implications of aberrant DNA methylation patterns in acute myelogenous leukemia.
    Galm O; Wilop S; Lüders C; Jost E; Gehbauer G; Herman JG; Osieka R
    Ann Hematol; 2005 Dec; 84 Suppl 1():39-46. PubMed ID: 16231140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concurrent methylation of promoters from tumor associated genes predicts outcome in acute myeloid leukemia.
    Hess CJ; Errami A; Berkhof J; Denkers F; Ossenkoppele GJ; Nygren AO; Schuurhuis GJ; Waisfisz Q
    Leuk Lymphoma; 2008 Jun; 49(6):1132-41. PubMed ID: 18569637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of FLT3 internal tandem duplication, nucleophosmin 1, and CEBPA gene mutations for acute myeloid leukemia patients with normal karyotype and younger than 60 years: a systematic review and meta-analysis.
    Port M; Böttcher M; Thol F; Ganser A; Schlenk R; Wasem J; Neumann A; Pouryamout L
    Ann Hematol; 2014 Aug; 93(8):1279-86. PubMed ID: 24801015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methylation of p15(INK4b) and E-cadherin genes is independently correlated with poor prognosis in acute myeloid leukemia.
    Shimamoto T; Ohyashiki JH; Ohyashiki K
    Leuk Res; 2005 Jun; 29(6):653-9. PubMed ID: 15863205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic factors in AML in relation to (ab)normal karyotype.
    Stone RM
    Best Pract Res Clin Haematol; 2009 Dec; 22(4):523-8. PubMed ID: 19959103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypermethylation of the GATA binding protein 4 (GATA4) promoter in Chinese pediatric acute myeloid leukemia.
    Tao YF; Fang F; Hu SY; Lu J; Cao L; Zhao WL; Xiao PF; Li ZH; Wang NN; Xu LX; Du XJ; Sun LC; Li YH; Li YP; Xu YY; Ni J; Wang J; Feng X; Pan J
    BMC Cancer; 2015 Oct; 15():756. PubMed ID: 26490736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deficient CEBPA DNA binding function in normal karyotype AML patients is associated with favorable prognosis.
    Fos J; Pabst T; Petkovic V; Ratschiller D; Mueller BU
    Blood; 2011 May; 117(18):4881-4. PubMed ID: 21389317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute myeloid leukemia with normal cytogenetics.
    Mawad R; Estey EH
    Curr Oncol Rep; 2012 Oct; 14(5):359-68. PubMed ID: 22806102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aberrant DNA methylation is a dominant mechanism in MDS progression to AML.
    Jiang Y; Dunbar A; Gondek LP; Mohan S; Rataul M; O'Keefe C; Sekeres M; Saunthararajah Y; Maciejewski JP
    Blood; 2009 Feb; 113(6):1315-25. PubMed ID: 18832655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute myeloid leukemia is characterized by Wnt pathway inhibitor promoter hypermethylation.
    Griffiths EA; Gore SD; Hooker C; McDevitt MA; Karp JE; Smith BD; Mohammad HP; Ye Y; Herman JG; Carraway HE
    Leuk Lymphoma; 2010 Sep; 51(9):1711-9. PubMed ID: 20795789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alteration of p73 in acute myelogenous leukemia.
    Sahu GR; Mishra R; Nagpal JK; Das BR
    Am J Hematol; 2005 May; 79(1):1-7. PubMed ID: 15849769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aberrant DNA methylation of a cell cycle regulatory pathway composed of P73, P15 and P57KIP2 is a rare event in children with acute lymphocytic leukemia.
    Canalli AA; Yang H; Jeha S; Hoshino K; Sanchez-Gonzalez B; Brandt M; Pierce S; Kantarjian H; Issa JP; Garcia-Manero G
    Leuk Res; 2005 Aug; 29(8):881-5. PubMed ID: 15978938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.